Monte Carlo simulation of the ISOLPHARM gamma camera for Ag-111 imaging
Fuente:
arXiv
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , |
|---|---|
| Format: | Preprint |
| Publié: |
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866910167696670720 |
|---|---|
| author | Serafini, D. Leso, A. Arzenton, A. Spadano, S. Borciani, E. Chen, D. Sbarra, C. Negrini, M. Margotti, A. Lanconelli, N. Baldazzi, G. Mariotti, E. Corradetti, S. Andrighetto, A. |
| author_facet | Serafini, D. Leso, A. Arzenton, A. Spadano, S. Borciani, E. Chen, D. Sbarra, C. Negrini, M. Margotti, A. Lanconelli, N. Baldazzi, G. Mariotti, E. Corradetti, S. Andrighetto, A. |
| contents | Targeted Radionuclide Therapy (TRT) is a well-established technique for cancer treatment. In this approach, radionuclides are bound to specific drugs that selectively transport them to the tumor site. Within the ISOLPHARM project, a radiopharmaceutical for TRT based on the innovative radionuclide Ag-111 is currently under development. Ag-111 has a half-life of 7.45 days and decays by emitting both electrons and gamma-rays. The emission of gamma-rays, predominantly at an energy of 342 keV, enables the visualization of Ag-111 using a gamma camera. In this work, we describe a Monte Carlo simulation developed to optimize the design parameters of such an imaging device. The simulation is based on the Geant4 toolkit, which accurately models the interactions between particles and matter. The estimated spatial resolution and sensitivity of the system are approximately 4 mm and 19 cps/MBq, respectively. The simulated device is able to resolve lesions with a lesion-to-background activity ratio of 4:1 under in-vivo-like conditions. These results indicate that the proposed gamma camera can provide cost-effective imaging capabilities for preclinical radiopharmaceutical studies. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2502_20112 |
| institution | arXiv |
| publishDate | 2025 |
| record_format | arxiv |
| spellingShingle | Monte Carlo simulation of the ISOLPHARM gamma camera for Ag-111 imaging Serafini, D. Leso, A. Arzenton, A. Spadano, S. Borciani, E. Chen, D. Sbarra, C. Negrini, M. Margotti, A. Lanconelli, N. Baldazzi, G. Mariotti, E. Corradetti, S. Andrighetto, A. Medical Physics Instrumentation and Detectors Targeted Radionuclide Therapy (TRT) is a well-established technique for cancer treatment. In this approach, radionuclides are bound to specific drugs that selectively transport them to the tumor site. Within the ISOLPHARM project, a radiopharmaceutical for TRT based on the innovative radionuclide Ag-111 is currently under development. Ag-111 has a half-life of 7.45 days and decays by emitting both electrons and gamma-rays. The emission of gamma-rays, predominantly at an energy of 342 keV, enables the visualization of Ag-111 using a gamma camera. In this work, we describe a Monte Carlo simulation developed to optimize the design parameters of such an imaging device. The simulation is based on the Geant4 toolkit, which accurately models the interactions between particles and matter. The estimated spatial resolution and sensitivity of the system are approximately 4 mm and 19 cps/MBq, respectively. The simulated device is able to resolve lesions with a lesion-to-background activity ratio of 4:1 under in-vivo-like conditions. These results indicate that the proposed gamma camera can provide cost-effective imaging capabilities for preclinical radiopharmaceutical studies. |
| title | Monte Carlo simulation of the ISOLPHARM gamma camera for Ag-111 imaging |
| topic | Medical Physics Instrumentation and Detectors |
| url | https://arxiv.org/abs/2502.20112 |